Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IRIDEX CORP Director's Dealing 2013

Sep 6, 2013

34978_dirs_2013-09-06_7ee938bf-772e-4614-b848-e6b4924af9f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2013-09-04

Reporting Person: NAUMANN-ETIENNE RUEDIGER (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-09-04 Common Stock P 15 $5.90 Acquired 56314 Direct
2013-09-05 Common Stock P 1001 $5.99 Acquired 57315 Direct
2013-09-06 Common Stock P 2584 $5.99 Acquired 59899 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 64019 Indirect

Footnotes

F1: The Reporting Person is a general partner of Intertec Healthcare Partners LP ("Intertec") and may be deemed to share voting and dispositive power of the shares held by Intertec. The Reporting Person disclaims beneficial ownership of the shares held by Intertec, except to the extent of his proportionate partnership interest therein.